Randomised, Placebo-controlled Safety and Pharmacokinetics Study of Novel Rifaximin Formulations in Healthy Volunteers

NCT04529811 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Rifaximin Novel Formulation
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.